285 related articles for article (PubMed ID: 25444855)
1. Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.
Deacon JC; Engelman DM; Barrera FN
Arch Biochem Biophys; 2015 Jan; 565():40-8. PubMed ID: 25444855
[TBL] [Abstract][Full Text] [Related]
2. Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.
Svoronos AA; Bahal R; Pereira MC; Barrera FN; Deacon JC; Bosenberg M; DiMaio D; Glazer PM; Engelman DM
Mol Pharm; 2020 Feb; 17(2):461-471. PubMed ID: 31855437
[TBL] [Abstract][Full Text] [Related]
3. pH-sensitive membrane peptides (pHLIPs) as a novel class of delivery agents.
Andreev OA; Engelman DM; Reshetnyak YK
Mol Membr Biol; 2010 Oct; 27(7):341-52. PubMed ID: 20939768
[TBL] [Abstract][Full Text] [Related]
4. Tuning the insertion properties of pHLIP.
Musial-Siwek M; Karabadzhak A; Andreev OA; Reshetnyak YK; Engelman DM
Biochim Biophys Acta; 2010 Jun; 1798(6):1041-6. PubMed ID: 19766589
[TBL] [Abstract][Full Text] [Related]
5. pHLIP-mediated translocation of membrane-impermeable molecules into cells.
Thévenin D; An M; Engelman DM
Chem Biol; 2009 Jul; 16(7):754-62. PubMed ID: 19635412
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic modeling reveals parameters that govern tumor targeting and delivery by a pH-Low Insertion Peptide (pHLIP).
Svoronos AA; Engelman DM
Proc Natl Acad Sci U S A; 2021 Jan; 118(1):. PubMed ID: 33443162
[TBL] [Abstract][Full Text] [Related]
7. Applications of pHLIP Technology for Cancer Imaging and Therapy.
Wyatt LC; Lewis JS; Andreev OA; Reshetnyak YK; Engelman DM
Trends Biotechnol; 2017 Jul; 35(7):653-664. PubMed ID: 28438340
[TBL] [Abstract][Full Text] [Related]
8. Peptides of pHLIP family for targeted intracellular and extracellular delivery of cargo molecules to tumors.
Wyatt LC; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
Proc Natl Acad Sci U S A; 2018 Mar; 115(12):E2811-E2818. PubMed ID: 29507241
[TBL] [Abstract][Full Text] [Related]
9. Mechanism and uses of a membrane peptide that targets tumors and other acidic tissues in vivo.
Andreev OA; Dupuy AD; Segala M; Sandugu S; Serra DA; Chichester CO; Engelman DM; Reshetnyak YK
Proc Natl Acad Sci U S A; 2007 May; 104(19):7893-8. PubMed ID: 17483464
[TBL] [Abstract][Full Text] [Related]
10. pHLIP Peptides Target Acidity in Activated Macrophages.
Visca H; DuPont M; Moshnikova A; Crawford T; Engelman DM; Andreev OA; Reshetnyak YK
Mol Imaging Biol; 2022 Dec; 24(6):874-885. PubMed ID: 35604527
[TBL] [Abstract][Full Text] [Related]
11. pH-Dependent Transmembrane Activity of Peptide-Functionalized Gold Nanostars for Computed Tomography/Photoacoustic Imaging and Photothermal Therapy.
Tian Y; Zhang Y; Teng Z; Tian W; Luo S; Kong X; Su X; Tang Y; Wang S; Lu G
ACS Appl Mater Interfaces; 2017 Jan; 9(3):2114-2122. PubMed ID: 28058834
[TBL] [Abstract][Full Text] [Related]
12. Roles of carboxyl groups in the transmembrane insertion of peptides.
Barrera FN; Weerakkody D; Anderson M; Andreev OA; Reshetnyak YK; Engelman DM
J Mol Biol; 2011 Oct; 413(2):359-71. PubMed ID: 21888917
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cancer cell proliferation and breast tumor targeting of pHLIP-monomethyl auristatin E conjugates.
Burns KE; Robinson MK; Thévenin D
Mol Pharm; 2015 Apr; 12(4):1250-8. PubMed ID: 25741818
[TBL] [Abstract][Full Text] [Related]
14. Family of pH (low) insertion peptides for tumor targeting.
Weerakkody D; Moshnikova A; Thakur MS; Moshnikova V; Daniels J; Engelman DM; Andreev OA; Reshetnyak YK
Proc Natl Acad Sci U S A; 2013 Apr; 110(15):5834-9. PubMed ID: 23530249
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the pHLIP transmembrane helix insertion pathway.
Karabadzhak AG; Weerakkody D; Wijesinghe D; Thakur MS; Engelman DM; Andreev OA; Markin VS; Reshetnyak YK
Biophys J; 2012 Apr; 102(8):1846-55. PubMed ID: 22768940
[TBL] [Abstract][Full Text] [Related]
16. Targeting diseased tissues by pHLIP insertion at low cell surface pH.
Andreev OA; Engelman DM; Reshetnyak YK
Front Physiol; 2014; 5():97. PubMed ID: 24659971
[TBL] [Abstract][Full Text] [Related]
17. Membrane-Induced p K
Vila-Viçosa D; Silva TFD; Slaybaugh G; Reshetnyak YK; Andreev OA; Machuqueiro M
J Chem Theory Comput; 2018 Jun; 14(6):3289-3297. PubMed ID: 29733633
[TBL] [Abstract][Full Text] [Related]
18. Targeting acidic diseased tissue: New technology based on use of the pH (Low) Insertion Peptide (pHLIP).
Andreev OA; Engelman DM; Reshetnyak YK
Chim Oggi; 2009 Mar; 27(2):34-37. PubMed ID: 20037661
[TBL] [Abstract][Full Text] [Related]
19. A monomeric membrane peptide that lives in three worlds: in solution, attached to, and inserted across lipid bilayers.
Reshetnyak YK; Segala M; Andreev OA; Engelman DM
Biophys J; 2007 Oct; 93(7):2363-72. PubMed ID: 17557792
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
